Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The Rise of Retail Investing Is Dangerous for DraftKings

While DKNG stock is appealing due to the underlying Golden Nugget acquisition, prospective buyers should exercise caution.

7 Biotech Stocks to Buy Amid the Delta Variant’s Onslaught

You may have thought the moment of relevancy for these biotech stocks was over, but the Delta variant has changed their prospects.

No Matter How the Pandemic Rolls, Mind Medicine Will Prevail

While MNMD stock is controversial due to its underlying psychedelic therapies, the broader narrative is exceptionally compelling.

7 Best Retirement Stocks to Buy to Build Long-Term Wealth

In a constantly changing world, your search for retirement stocks should focus on sectors that will be relevant for decades to come.

7 Penny Stocks That Have That ‘Get Rich’ Potential

If you want to travel on the speculative side of the market, these penny stocks might have the right stuff for you to strike it rich.